Showing results (11-20 of 36) with videos related to
Sort By:
Pageof 4
International Journal of Molecular Sciences|December 30, 2025
Pro-Inflammatory Macrophage Phenotype Skewing Induced by Tumor Treating Fields (TTFields)Tal Kan, Yiftah Barsheshet, Tharwat Haj Khalil, et al.Frontiers in Oncology|July 12, 2021
In Vivo Safety of Tumor Treating Fields (TTFields) Applied to the TorsoRoni Blatt, Shiri Davidi, Mijal Munster, et al.Seminars in Oncology|September 13, 2014
Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivoMoshe Giladi, Uri Weinberg, Rosa S Schneiderman, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|March 9, 2017
Using computational phantoms to improve delivery of Tumor Treating Fields (TTFields) to patientsZe'ev Bomzon, Hadas Sara Hershkovich, Noa Urman, et al.Cell Death & Disease|October 21, 2018
AMPK-dependent autophagy upregulation serves as a survival mechanism in response to Tumor Treating Fields (TTFields)Anna Shteingauz, Yaara Porat, Tali Voloshin, et al.Journal of Visualized Experiments : Jove|May 19, 2017
Determining the Optimal Inhibitory Frequency for Cancerous Cells Using Tumor Treating Fields (TTFields)Yaara Porat, Moshe Giladi, Rosa S Schneiderman, et al.Cancers|October 21, 2020
Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting DynamicsTali Voloshin, Rosa Sara Schneiderman, Alexandra Volodin, et al.Radiation Oncology (London, England)|December 30, 2017
Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cellsMoshe Giladi, Mijal Munster, Rosa S Schneiderman, et al.Scientific Reports|December 15, 2015
Mitotic Spindle Disruption by Alternating Electric Fields Leads to Improper Chromosome Segregation and Mitotic Catastrophe in Cancer CellsMoshe Giladi, Rosa S Schneiderman, Tali Voloshin, et al.Cancer Immunology, Immunotherapy : CII|March 8, 2020
Tumor-treating fields (TTFields) induce immunogenic cell death resulting in enhanced antitumor efficacy when combined with anti-PD-1 therapyTali Voloshin, Noa Kaynan, Shiri Davidi, et al.Pageof 4